NSDL, India’s largest depository, is launching a ₹3,000 crore IPO in March, entirely as an offer for sale. Key banking stocks ...

After an improving IPO market in 2024, the IPO market may fare well in 2025, especially with some hot names on deck. That ...

Metsera's IPO raised $316.2 million, funding its obesity drug MET-097i, which shows promise with once-monthly dosing. Read ...

ThoughtSpot offers cloud-based solutions to finding and analyzing data in an accurate, rapid, user-friendly manner. Launching ...

Guggenheim has initiated coverage of Metsera (NASDAQ:MTSR) with a buy rating, citing the company's obesity drug candidates.

Basel Medical Group (NASDAQ:BMGL) shares were up 4% in late afternoon trading Tuesday following a $9M U.S. initial public ...

A brief history of Netflix stock. Netflix was founded in 1997 as a competitor to Blockbuster, operating a DVD-by-mail rental ...

Nearly half of the new-age companies listed since 2021 are trading below their IPO price. This and more in today’s ETtech Top ...

Guggenheim analyst sees significant upside in Metsera stock to $56. MTSR is working on both injectable and oral weight-loss ...

Paytm, Delhivery, and Honasa are the top losers, while Zomato and PB Fintech have stood up successfully against the market ...

Tata Capital Ltd. said it’s planning to go public in what may be one of India’s largest initial public offerings of the year.